Pharmacological treatments available for the management of underactive bladder in neurological conditions

References

• Fowler CJ, Griffiths D, De Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453–466.
   PubMed Web of Science ®Google Scholar
• Kroll P. Pharmacotherapy for pediatric neurogenic bladder. Paediatr Drugs. 2017;19(5):463–478.
   PubMed Web of Science ®Google Scholar
• Chapple CR, Osman NI, Birder L, et al. The underactive bladder: a new clinical concept? Eur Urol. 2015;68(3):351–353.
   PubMed Web of Science ®Google Scholar
• Osman NI, Chapple CR, Abrams P, et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014;65(2):389–398.
   PubMed Web of Science ®Google Scholar
• Hoag N, Gani J. Underactive bladder: clinical features, urodynamic parameters, and treatment. Int Neurourol J. 2015;19(3):185–189.
   PubMed Web of Science ®Google Scholar
• Li X, Liao L. Updates of underactive bladder: a review of the recent literature. Int Urol Nephrol. 2016;48(6):919–930.
   PubMed Web of Science ®Google Scholar
• Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.
   PubMed Web of Science ®Google Scholar
• Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children’s Continence Society. Neurourol Urodyn. 2016;35(4):471–481.
   PubMed Web of Science ®Google Scholar
• Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int. 2004;93(6):745–750.
   PubMed Web of Science ®Google Scholar
• Fode M, Sonksen J. Towards a greater understanding of underactive bladder. Eur Urol. 2017;72(3):408–409.
   Web of Science ®Google Scholar
• van Koeveringe GA, Vahabi B, Andersson KE, et al. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn. 2011;30(5):723–728.
   PubMed Web of Science ®Google Scholar
• Chancellor MB, Kaufman J. Case for pharmacotherapy development for underactive bladder. Urology. 2008;72(5):966–967.
   PubMed Web of Science ®Google Scholar
• Chapple C, Osman N. The underactive detrussor. In: Wein A, Kavoussi L, Partin A, et al., editors. Campbell-Walsh urology. Eleventh ed. Philadelphia: Elsevier; 2016. p.1807–1820.
   Google Scholar
• Cohn JA, Brown ET, Kaufman MR, et al. Underactive bladder in women: is there any evidence? Curr Opin Urol. 2016;26(4):309–314.
   PubMed Web of Science ®Google Scholar
• Taylor JA 3rd, Kuchel GA. Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc. 2006;54(12):1920–1932.
   PubMed Web of Science ®Google Scholar
• Abarbanel J, Marcus EL. Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urology. 2007;69(3):436–440.
   PubMed Web of Science ®Google Scholar
• Belenky A, Abarbanel Y, Cohen M, et al. Detrusor resistive index evaluated by Doppler ultrasonography as a potential indicator of bladder outlet obstruction. Urology. 2003;62(4):647–650.
   PubMed Web of Science ®Google Scholar
• Suskind AM, Smith PP. A new look at detrusor underactivity: impaired contractility versus afferent dysfunction. Curr Urol Rep. 2009;10(5):347–351.
   PubMedGoogle Scholar
• Chapple CR, Osman NI. Crystallizing the definition of underactive bladder syndrome, a common but under-recognized clinical entity. Low Urin Tract Symptoms. 2015;7(2):71–76.
   PubMed Web of Science ®Google Scholar
• Miyazato M, Yoshimura N, Chancellor MB. The other bladder syndrome: underactive bladder. Rev Urol. 2013;15(1):11–22.
   PubMedGoogle Scholar
• Aldamanhori R, Chapple CR. Underactive bladder, detrusor underactivity, definition, symptoms, epidemiology, etiopathogenesis, and risk factors. Curr Opin Urol. 2017;27(3):293–299.
   PubMed Web of Science ®Google Scholar
• Osman NI, Chapple CR. Contemporary concepts in the aetiopathogenesis of detrusor underactivity. Nat Rev Urol. 2014;11(11):639–648.
   PubMed Web of Science ®Google Scholar
• Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004;84(3):935–986.
   PubMed Web of Science ®Google Scholar
• Brierly RD, Hindley RG, McLarty E, et al. A prospective controlled quantitative study of ultrastructural changes in the underactive detrusor. J Urol. 2003;169(4):1374–1378.
   PubMed Web of Science ®Google Scholar
• Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility. J Urol. 1993;150(5 Pt 2):1657–1667.
   PubMed Web of Science ®Google Scholar
• Kuo HC. Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction. Urology. 2007;69(1): 57–61; discussion 61–62.
   PubMed Web of Science ®Google Scholar
• Gammie A, Kaper M, Dorrepaal C, et al. Signs and symptoms of detrusor underactivity: an analysis of clinical presentation and urodynamic tests from a large group of patients undergoing pressure flow studies. Eur Urol. 2016;69(2):361–369.
   PubMed Web of Science ®Google Scholar
• Kadow BT, Tyagi P, Chermansky CJ. Neurogenic causes of detrusor underactivity. Curr Bladder Dysfunct Rep. 2015;10(4):325–331.
   PubMed Web of Science ®Google Scholar
• Ismail SI, Emery SJ. The prevalence of silent postpartum retention of urine in a heterogeneous cohort. J Obstet Gynaecol. 2008;28(5):504–507.
   PubMedGoogle Scholar
• Bors E, Turner RD. History and physical examination in neurological urology. J Urol. 1960;83:759–767.
   PubMed Web of Science ®Google Scholar
• Drake MJ, Apostolidis A, Cocci A, et al. Neurogenic lower urinary tract dysfunction: clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence 2013. Neurourol Urodyn. 2016;35(6):657–665.
   PubMed Web of Science ®Google Scholar
• Stohrer M, Goepel M, Kondo A, et al. The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn. 1999;18(2):139–158.
   PubMed Web of Science ®Google Scholar
• Reynard JM, Peters TJ, Lim C, et al. The value of multiple free-flow studies in men with lower urinary tract symptoms. Br J Urol. 1996;77(6):813–818.
   PubMedGoogle Scholar
• Schurch B, Schmid DM, Kaegi K. Value of sensory examination in predicting bladder function in patients with T12-L1 fractures and spinal cord injury. Arch Phys Med Rehabil. 2003;84(1):83–89.
   PubMed Web of Science ®Google Scholar
• Sonke GS, Kiemeney LA, Verbeek AL, et al. Low reproducibility of maximum urinary flow rate determined by portable flowmetry. Neurourol Urodyn. 1999;18(3):183–191.
   PubMed Web of Science ®Google Scholar
• Oelke M, Rademakers KL, van Koeveringe GA. Unravelling detrusor underactivity: development of a bladder outlet resistance-bladder contractility nomogram for adult male patients with lower urinary tract symptoms. Neurourol Urodyn. 2016;35(8):980–986.
   PubMed Web of Science ®Google Scholar
• Frimodt-Moller C. Diabetic cystopathy: epidemiology and related disorders. Ann Intern Med. 1980;92(2 Pt 2):318–321.
   PubMed Web of Science ®Google Scholar
• Ueda T, Yoshimura N, Yoshida O. Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol. 1997;157(2):580–584.
   PubMed Web of Science ®Google Scholar
• Kocsis JD, Malenka RC, Waxman SG. Enhanced parallel fiber frequency-following after reduction of postsynaptic activity. Brain Res. 1981;207(2):321–331.
   PubMed Web of Science ®Google Scholar
• Burney TL, Senapati M, Desai S, et al. Acute cerebrovascular accident and lower urinary tract dysfunction: a prospective correlation of the site of brain injury with urodynamic findings. J Urol. 1996;156(5):1748–1750.
   PubMed Web of Science ®Google Scholar
• Araki I, Kitahara M, Oida T, et al. Voiding dysfunction and Parkinson’s disease: urodynamic abnormalities and urinary symptoms. J Urol. 2000;164(5):1640–1643.
   PubMed Web of Science ®Google Scholar
• Uchiyama T, Sakakibara R, Yamamoto T, et al. Urinary dysfunction in early and untreated Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2011;82(12):1382–1386.
   PubMed Web of Science ®Google Scholar
• Haensch CA, Jorg J. Autonomic dysfunction in multiple sclerosis. J Neurol. 2006;253(Suppl 1):I3–9.
   PubMed Web of Science ®Google Scholar
• DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs. 2003;63(2):153–166.
   PubMed Web of Science ®Google Scholar
• Aharony S, Lam O, Lapierre Y, et al. Multiple sclerosis (MS) for the urologist: what should urologists know about MS? Neurourol Urodyn. 2016;35(2):174–179.
   PubMed Web of Science ®Google Scholar
• Wosnitzer MS, Walsh R, Rutman MP. The use of sacral neuromodulation for the treatment of non-obstructive urinary retention secondary to Guillain-Barre syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(9):1145–1147.
   PubMed Web of Science ®Google Scholar
• van Koeveringe GA, Rademakers KL, Birder LA, et al. Detrusor underactivity: pathophysiological considerations, models and proposals for future research. ICI-RS 2013. Neurourol Urodyn. 2014;33(5):591–596.
   PubMed Web of Science ®Google Scholar
• Tyagi P, Smith PP, Kuchel GA, et al. Pathophysiology and animal modeling of underactive bladder. Int Urol Nephrol. 2014;46(Suppl 1):S11–21.
   PubMedGoogle Scholar
• Yoshida M, Masunaga K, Nagata T, et al. The effects of chronic hyperlipidemia on bladder function in myocardial infarction-prone Watanabe heritable hyperlipidemic (WHHLMI) rabbits. Neurourol Urodyn. 2010;29(7):1350–1354.
   PubMed Web of Science ®Google Scholar
• Bhalerao VM, Gedam BS, Mukharjee AK. Herpes zoster infection presenting with urinary retention and constipation. J Assoc Physicians India. 2015;63(7):63–65.
   PubMedGoogle Scholar
• Gyrtrup HJ, Kristiansen VB, Zachariae CO, et al. Voiding problems in patients with HIV infection and AIDS. Scand J Urol Nephrol. 1995;29(3):295–298.
   PubMed Web of Science ®Google Scholar
• Khan Z, Singh VK, Yang WC. Neurogenic bladder in acquired immune deficiency syndrome (AIDS). Urology. 1992;40(3):289–291.
   PubMed Web of Science ®Google Scholar
• Hattori T, Yasuda K, Kita K, et al. Disorders of micturition in tabes dorsalis. Br J Urol. 1990;65(5):497–499.
   PubMedGoogle Scholar
• Diernaes JE, Elsner JS, Vestergaard C. Novel presentation of rituximab-induced herpes zoster: urinary retention and acute kidney failure. J Eur Acad Dermatol Venereol. 2016;30(1):135–136.
   PubMed Web of Science ®Google Scholar
• Addison B, Harvey M. Herpes zoster-induced acute urinary retention. Emerg Med Australas. 2013;25(3):279–281.
   PubMed Web of Science ®Google Scholar
• Chancellor MB. The overactive bladder progression to underactive bladder hypothesis. Int Urol Nephrol. 2014;46(Suppl 1):S23–27.
   PubMedGoogle Scholar
• Stohrer M, Blok B, Castro-Diaz D, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009;56(1):81–88.
   PubMed Web of Science ®Google Scholar
• Minardi D, d’Anzeo G, Parri G, et al. The role of uroflowmetry biofeedback and biofeedback training of the pelvic floor muscles in the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a randomized controlled prospective study. Urology. 2010;75(6):1299–1304.
   PubMed Web of Science ®Google Scholar
• de Jong TP, Klijn AJ, Vijverberg MA, et al. Effect of biofeedback training on paradoxical pelvic floor movement in children with dysfunctional voiding. Urology. 2007;70(4):790–793.
   PubMed Web of Science ®Google Scholar
• Ladi Seyedian SS, Sharifi-Rad L, Ebadi M, et al. Combined functional pelvic floor muscle exercises with Swiss ball and urotherapy for management of dysfunctional voiding in children: a randomized clinical trial. Eur J Pediatr. 2014;173(10):1347–1353.
   PubMed Web of Science ®Google Scholar
• Ladi-Seyedian S, Kajbafzadeh AM, Sharifi-Rad L, et al. Management of non-neuropathic underactive bladder in children with voiding dysfunction by animated biofeedback: a randomized clinical trial. Urology. 2015;85(1):205–210.
   PubMed Web of Science ®Google Scholar
• Webb RJ, Lawson AL, Neal DE. Clean intermittent self-catheterisation in 172 adults. Br J Urol. 1990;65(1):20–23.
   PubMedGoogle Scholar
• Hegde SS. Muscarinic receptors in the bladder: from basic research to therapeutics. Br J Pharmacol. 2006;147(Suppl 2):S80–87.
   PubMedGoogle Scholar
• Abrams P, Andersson KE, Buccafusco JJ, et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006;148(5):565–578.
   PubMed Web of Science ®Google Scholar
• Fowler CJ. Neurological disorders of micturition and their treatment. Brain. 1999;122(Pt 7):1213–1231.
   PubMedGoogle Scholar
• Casanova N, McGuire E, Fenner DE. Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity. Int J Gynaecol Obstet. 2006;95(3):305–311.
   PubMed Web of Science ®Google Scholar
• Barendrecht MM, Oelke M, Laguna MP, et al. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int. 2007;99(4):749–752.
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Chancellor MB. Differential diagnosis and treatment of impaired bladder emptying. Rev Urol. 2004;6(Suppl 1):S24–31.
   PubMedGoogle Scholar
• Kemp B, Kitschke HJ, Goetz M, et al. Prophylaxis and treatment of bladder dysfunction after Wertheim-Meigs operation: the positive effect of early postoperative detrusor stimulation using the cholinergic drug betanecholchloride. Int Urogynecol J Pelvic Floor Dysfunct. 1997;8(3):138–141.
   PubMedGoogle Scholar
• Sakurai T, Uchida K, Oda M, et al. Postprostatectomy dysuria: restored voiding function by perineal hot water spray in an old male with a contractile bladder. Nihon Hinyokika Gakkai Zasshi. 1997;88(5):580–583.
   PubMedGoogle Scholar
• Burger DH, Kappetein AP, Boutkan H, et al. Prevention of urinary retention after general surgery: a controlled trial of carbachol/diazepam versus alfusozine. J Am Coll Surg. 1997;185(3):234–236.
   PubMed Web of Science ®Google Scholar
• Gottesman L, Milsom JW, Mazier WP. The use of anxiolytic and parasympathomimetic agents in the treatment of postoperative urinary retention following anorectal surgery. A prospective, randomized, double-blind study. Dis Colon Rectum. 1989;32(10):867–870.
   PubMed Web of Science ®Google Scholar
• Yamanishi T, Yasuda K, Kamai T, et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol. 2004;11(2):88–96.
   PubMed Web of Science ®Google Scholar
• Hindley RG, Brierly RD, Thomas PJ. Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity. BJU Int. 2004;93(1):89–92.
   PubMed Web of Science ®Google Scholar
• Barrett DM. The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol. 1981;126(5):640–642.
   PubMed Web of Science ®Google Scholar
• Bougas DA, Mitsogiannis IC, Mitropoulos DN, et al. Clinical efficacy of distigmine bromide in the treatment of patients with underactive detrusor. Int Urol Nephrol. 2004;36(4):507–512.
   PubMedGoogle Scholar
• Savona-Ventura C, Grech ES, Saliba I. Pharmacological measures to prevent post-operative urinary retention; a prospective randomized study. Eur J Obstet Gynecol Reprod Biol. 1991;41(3):225–229.
   PubMed Web of Science ®Google Scholar
• Barendrecht MM, Chichester P, Michel MC, et al. Effect of short-term outlet obstruction on rat bladder nerve density and contractility. Auton Autacoid Pharmacol. 2007;27(1):47–53.
   PubMedGoogle Scholar
• Taylor P. Anticholinesterase agents. In: Brunton L, Lazo J, Parker K, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Companies, Inc.; 2006. p. 211–212.
   Google Scholar
• Harada T, Fushimi K, Kato A, et al. Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity. Biol Pharm Bull. 2010;33(4):653–658.
   PubMed Web of Science ®Google Scholar
• Witsell DL, Stinnett S, Chambers MS. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia. Head Neck. 2012;34(8):1136–1142.
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Hattori T, Uchiyama T, et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst. 2000;79(2–3):191–195.
   PubMedGoogle Scholar
• Chang SJ, Chiang IN, Yu HJ. The effectiveness of tamsulosin in treating women with voiding difficulty. Int J Urol. 2008;15(11):981–985.
   PubMed Web of Science ®Google Scholar
• Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev. 2004;56(4):581–631.
   PubMed Web of Science ®Google Scholar
• Andersson KE. Detrusor underactivity/underactive bladder: new research initiatives needed. J Urol. 2010;184(5):1829–1830.
   PubMed Web of Science ®Google Scholar
• Yeh JZ, Oxford GS, Wu CH, et al. Dynamics of aminopyridine block of potassium channels in squid axon membrane. J Gen Physiol. 1976;68(5):519–535.
   PubMed Web of Science ®Google Scholar
• Ulbricht W, Wagner HH. Block of potassium channels of the nodal membrane by 4-aminopyridine and its partial removal on depolarization. Pflugers Arch. 1976;367(1):77–87.
   PubMed Web of Science ®Google Scholar
• Boev K, Bonev A, Papasova M. 4-Aminopyridine-induced changes in the electrical and contractile activities of the gastric smooth muscle. Gen Physiol Biophys. 1985;4(6):589–595.
   PubMed Web of Science ®Google Scholar
• Jancso G, Maggi CA. Distribution of capsaicin-sensitive urinary bladder afferents in the rat spinal cord. Brain Res. 1987;418(2):371–376.
   PubMed Web of Science ®Google Scholar
• Maggi CA, Santicioli P, Borsini F, et al. The effect of 4-aminopyridine on micturition reflex in normal or capsaicin-desensitized rats. Brain Res. 1988;449(1–2):61–70.
   PubMed Web of Science ®Google Scholar
• Cardenas DD, Ditunno JF, Graziani V, et al. Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury. Spinal Cord. 2014;52(1):70–76.
   PubMed Web of Science ®Google Scholar
• Wu ZZ, Li DP, Chen SR, et al. Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit. J Biol Chem. 2009;284(52):36453–36461.
   PubMed Web of Science ®Google Scholar
• Dmitrieva N, Berkley KJ. Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus. J Neurosci. 2002;22(16):7147–7153.
   PubMed Web of Science ®Google Scholar
• Consroe P, Musty R, Rein J, et al. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol. 1997;38(1):44–48.
   PubMed Web of Science ®Google Scholar
• Pertwee RG, Fernando SR. Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol. 1996;118(8):2053–2058.
   PubMed Web of Science ®Google Scholar
• Malinowska B, Piszcz J, Koneczny B, et al. Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch Pharmacol. 2001;364(3):233–241.
   PubMed Web of Science ®Google Scholar
• Pataky Z, Gasteyger C, Ziegler O, et al. Efficacy of rimonabant in obese patients with binge eating disorder. Exp Clin Endocrinol Diabetes. 2013;121(1):20–26.
   PubMed Web of Science ®Google Scholar
• Everaerts W, Gevaert T, Nilius B, et al. On the origin of bladder sensing: Tr(i)ps in urology. Neurourol Urodyn. 2008;27(4):264–273.
   PubMed Web of Science ®Google Scholar
• Everaerts W, Nilius B, Owsianik G. The vanilloid transient receptor potential channel TRPV4: from structure to disease. Prog Biophys Mol Biol. 2010;103(1):2–17.
   PubMed Web of Science ®Google Scholar
• Everaerts W, de Ridder D. Unravelling the underactive bladder: a role for TRPV4? BJU Int. 2013;111(2):353–354.
   PubMed Web of Science ®Google Scholar
• Aizawa N, Wyndaele JJ, Homma Y, et al. Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat. Neurourol Urodyn. 2012;31(1):148–155.
   PubMed Web of Science ®Google Scholar
• Young JS, Johnston L, Soubrane C, et al. The passive and active contractile properties of the neurogenic, underactive bladder. BJU Int. 2013;111(2):355–361.
   PubMed Web of Science ®Google Scholar
• Yoshii K, Hirayama M, Nakamura T, et al. Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach. J Pharm Sci. 2011;100(11):4965–4973.
   PubMed Web of Science ®Google Scholar
• Doi Y, Murasaki O, Kaibara M, et al. Characterization of functional effects of Z-338, a novel gastroprokinetic agent, on the muscarinic M1, M2, and M3 receptors expressed in Xenopus oocytes. Eur J Pharmacol. 2004;505(1–3):31–35.
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Akiyama T, Shimizu N, et al. A pilot study of acotiamide hydrochloride hydrate in patients with detrusor underactivity. Res Rep Urol. 2015;7:81–83.
   PubMed Web of Science ®Google Scholar
• Tonini M, Messori E, Franceschetti GP, et al. Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. Br J Pharmacol. 1994;113(1):1–2.
   PubMed Web of Science ®Google Scholar
• Candura SM, Messori E, Franceschetti GP, et al. Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists. Br J Pharmacol. 1996;118(8):1965–1970.
   PubMed Web of Science ®Google Scholar
• Ramage AG. The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition. Br J Pharmacol. 2006;147(Suppl 2):S120–131.
   PubMedGoogle Scholar
• Franco I. Underactive bladder in children. In: Chancellor MB, Diokno AC, editors. The underactive bladder. Switzerland: Springer; 2016. p. 189–206.
   Google Scholar
• MacDonald SW, Karlsson S, Rieckmann A, et al. Aging-related increases in behavioral variability: relations to losses of dopamine D1 receptors. J Neurosci. 2012;32(24):8186–8191.
   PubMed Web of Science ®Google Scholar
• Brusa L, Petta F, Pisani A, et al. Central acute D2 stimulation worsens bladder function in patients with mild Parkinson’s disease. J Urol. 2006;175(1):202–206. discussion 206–207.
   PubMed Web of Science ®Google Scholar
• Uchiyama T, Sakakibara R, Yoshiyama M, et al. Biphasic effect of apomorphine, an anti-parkinsonian drug, on bladder function in rats. Neuroscience. 2009;162(4):1333–1338.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Miyamae K, Iwashita H, et al. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology. 2004;63(3 Suppl 1):17–23.
   PubMedGoogle Scholar
• Beckel JM, Daugherty SL, Tyagi P, et al. Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder. J Physiol. 2015;593(8):1857–1871.
   PubMed Web of Science ®Google Scholar
• Smith PP, DeAngelis A, Kuchel GA. Detrusor expulsive strength is preserved, but responsiveness to bladder filling and urinary sensitivity is diminished in the aging mouse. Am J Physiol Regul Integr Comp Physiol. 2012;302(5):R577–586.
   PubMed Web of Science ®Google Scholar
• Phelan MW, Franks M, Somogyi GT, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol. 2001;165(4):1107–1110.
   PubMed Web of Science ®Google Scholar
• Smith CP, Somogyi GT, Chancellor MB. Botulinum toxin: poisoning the spastic bladder and urethra. Rev Urol. 2002;4(2):61–68.
   PubMedGoogle Scholar
• Liao YM, Kuo HC. Causes of failed urethral botulinum toxin A treatment for emptying failure. Urology. 2007;70(4):763–766.
   PubMed Web of Science ®Google Scholar
• Kaplan WE. Intravesical electrical stimulation of the bladder: pro. Urology. 2000;56(1):2–4.
   PubMed Web of Science ®Google Scholar
• Ebner A, Jiang C, Lindstrom S. Intravesical electrical stimulation–an experimental analysis of the mechanism of action. J Urol. 1992;148(3):920–924.
   PubMed Web of Science ®Google Scholar
• Primus G, Kramer G, Pummer K. Restoration of micturition in patients with acontractile and hypocontractile detrusor by transurethral electrical bladder stimulation. Neurourol Urodyn. 1996;15(5):489–497.
   PubMed Web of Science ®Google Scholar
• Lombardi G, Musco S, Celso M, et al. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience. Spinal Cord. 2014;52(3):241–245.
   PubMed Web of Science ®Google Scholar
• Swinn MJ, Kitchen ND, Goodwin RJ, et al. Sacral neuromodulation for women with Fowler’s syndrome. Eur Urol. 2000;38(4):439–443.
   PubMed Web of Science ®Google Scholar
• Kajbafzadeh AM, Sharifi-Rad L, Ladi-Seyedian SS, et al. Transcutaneous interferential electrical stimulation for the management of non-neuropathic underactive bladder in children: a randomised clinical trial. BJU Int. 2016;117(5):793–800.
   PubMed Web of Science ®Google Scholar
• Thorner DA, Blaivas JG, Tsui JF, et al. Outcomes of reduction cystoplasty in men with impaired detrusor contractility. Urology. 2014;83(4):882–886.
   PubMed Web of Science ®Google Scholar
• Gakis G, Ninkovic M, van Koeveringe GA, et al. Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol. 2011;185(2):593–599.
   PubMed Web of Science ®Google Scholar
• Moreno-Palacios J, Maldonado-Alcaraz E, Montoya-Martinez G, et al. Outcomes and complications of sphincterotomy with bladder neck incision in neurologically healthy male patients with voiding dysfunction. Arch Esp Urol. 2012;65(2):244–250.
   PubMed Web of Science ®Google Scholar
• Jhang JF, Jiang YH, Kuo HC. Transurethral incision of the bladder neck improves voiding efficiency in female patients with detrusor underactivity. Int Urogynecol J. 2014;25(5):671–676.
   PubMed Web of Science ®Google Scholar
• Kajbafzadeh AM, Chubak N. Simultaneous Malone antegrade continent enema and Mitrofanoff principle using the divided appendix: report of a new technique for prevention of stoma complications. J Urol. 2001;165(6 Pt 2):2404–2409.
   PubMed Web of Science ®Google Scholar
• Kari J, Al-Deek B, Elkhatib L, et al. Is mitrofanoff a more socially accepted clean intermittent catheterization (CIC) route for children and their families? Eur J Pediatr Surg. 2013;23(5):405–410.
   PubMed Web of Science ®Google Scholar
• Mhiri MN, Bahloul A, Chabchoub K. Mitrofanoff appendicovesicostomy in children: indication and results. Prog Urol. 2007;17(2):245–249.
   PubMed Web of Science ®Google Scholar
• Nishijima S, Sugaya K, Miyazato M, et al. Restoration of bladder contraction by bone marrow transplantation in rats with underactive bladder. Biomed Res. 2007;28(5):275–280.
   PubMed Web of Science ®Google Scholar
• Huard J, Yokoyama T, Pruchnic R, et al. Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther. 2002;9(23):1617–1626.
   PubMed Web of Science ®Google Scholar
• Levanovich PE, Diokno A, Hasenau DL, et al. Intradetrusor injection of adult muscle-derived cells for the treatment of underactive bladder: pilot study. Int Urol Nephrol. 2015;47(3):465–467.
   PubMed Web of Science ®Google Scholar
• Chancellor MB, Yoshimura N, Pruchnic R, et al. Gene therapy strategies for urological dysfunction. Trends Mol Med. 2001;7(7):301–306.
   PubMed Web of Science ®Google Scholar
• Abdel-Halim RE, Abdel-Maguid TE. The functional anatomy of the uretero-vesical junction. A historical review. Saudi Med J. 2003;24(8):815–819.
   PubMed Web of Science ®Google Scholar
• Grafstein NH, Combs AJ, Glassberg KI. Primary bladder neck dysfunction: an overlooked entity in children. Curr Urol Rep. 2005;6(2):133–139.
   PubMedGoogle Scholar
• Kajbafzadeh AM, Baradaran N, Sadeghi Z, et al. Vesicoureteral reflux and primary bladder neck dysfunction in children: urodynamic evaluation and randomized, double-blind, clinical trial on effect of alpha-blocker therapy. J Urol. 2010;184(5):2128–2133.
   PubMed Web of Science ®Google Scholar
• Kajbafzadeh AM, Payabvash S, Karimian G. Urodynamic changes in patients with anterior urethral valves: before and after endoscopic valve ablation. J Pediatr Urol. 2007;3(4):295–300.
   PubMedGoogle Scholar
• van Batavia JP, Combs AJ, Horowitz M, et al. Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy. J Urol. 2010;183(2):724–730.
   PubMed Web of Science ®Google Scholar
• Keihani S, Kajbafzadeh AM, Kameli SM, et al. Long-term impacts of concurrent posterior urethral valve ablation and bladder neck incision on urinary continence and ejaculation. Urology. 2017;99:278–280.
   PubMed Web of Science ®Google Scholar